MH

Michael C. Holmes

ST Sangamo Therapeutics: 7 patents #4 of 45Top 9%
OS Ospedale San Raffaele S.R.L.: 3 patents #2 of 26Top 8%
FT Fondazione Telethon: 1 patents #2 of 13Top 20%
University Of Texas System: 1 patents #80 of 560Top 15%
🗺 California: #1,935 of 60,411 inventorsTop 4%
Overall (2018): #13,551 of 503,207Top 3%
7
Patents 2018

Issued Patents 2018

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10155011 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Maria Chiara Bonini, Pietro Genovese, Philip D. Gregory, Luigi Naldini, David Paschon +2 more 2018-12-18
10117899 Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells Pietro Genovese, Philip D. Gregory, Angelo Leone Lombardo, Luigi Naldini 2018-11-06
10072062 Methods and compositions for modification of a HLA locus Trevor Collingwood, Laurence J.N. COOPER, Philip D. Gregory, Jeffrey C. Miller, Edward J. Rebar +2 more 2018-09-11
10046028 Methods and compositions for modulating PD1 Philip D. Gregory, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik +1 more 2018-08-14
9963715 Methods and compositions for treatment of a genetic condition Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Jeffrey C. Miller, David Paschon +4 more 2018-05-08
9957526 Delivery methods and compositions for nuclease-mediated genome engineering Jianbin Wang 2018-05-01
9937207 Targeted disruption of T cell receptor genes using talens Philip D. Gregory, David Paschon, Lei Zhang, Maria Chiara Bonini, Pietro Genovese +3 more 2018-04-10